liu.seSearch for publications in DiVA
Change search
Link to record
Permanent link

Direct link
BETA
Duchén, Karel
Alternative names
Publications (10 of 30) Show all publications
van Vliet, J. S., Gustafsson, P., Duchén, K. & Nelson Follin, N. (2015). Social inequality and age-specific gender differences in overweight and perception of overweight among Swedish children and adolescents: a cross-sectional study. BMC Public Health, 15(628)
Open this publication in new window or tab >>Social inequality and age-specific gender differences in overweight and perception of overweight among Swedish children and adolescents: a cross-sectional study
2015 (English)In: BMC Public Health, ISSN 1471-2458, E-ISSN 1471-2458, Vol. 15, no 628Article in journal (Refereed) Published
Abstract [en]

Background: Overweight among children and adolescents related to social inequality, as well as age and gender differences, may contribute to poor self-image, thereby raising important public health concerns. This study explores social inequality in relation to overweight and perception of overweight among 263 boys and girls, age 7 to 17, in Vaxjo, Sweden. Methods: Data were obtained through a questionnaire and from physical measurements of height, weight and waist circumference [WC]. To assess social, age and gender differences in relation to overweight, the independent sample t- and chi-square tests were used, while logistic regression modeling was used to study determinants for perception of overweight. Results: Social inequality and gender differences as they relate to high ISO-BMI [Body Mass Index for children] and WC were associated with low maternal socioeconomic status [SES] among boys less than 13 years [mean age = 10.4; n = 65] and with low paternal education level among boys = 13 years [mean age = 15.0; n = 39] [p less than 0.05]. One suggested explanation for this finding is maternal impact on boys during childhood and the influence of the father as a role model for adolescent boys. The only association found among girls was between high ISO-BMI in girls = 13 years [mean age = 15.0; n = 74] and low paternal occupational status. Concerning perception of overweight, age and gender differences were found, but social inequality was not the case. Among boys and girls less than 13 years, perception of overweight increased only when overweight was actually present according to BMI or WC [p less than 0.01]. Girls = 13 years [mean age = 15.0] were more likely to unrealistically perceive themselves as overweight or "too fat," despite factual measurements to the contrary, than boys [p less than 0.05] and girls less than 13 years [mean age = 10.4; n = 83] [p less than 0.001]. Conclusions: The association between social inequality and overweight in adolescence in this study is age-and gender-specific. Gender differences, especially in perception of overweight, tend to increase with age, indicating that adolescence is a crucial period. When planning interventions to prevent overweight and obesity among children and adolescents, parental SES as well as age and gender-specific differences in social norms and perception of body weight status should be taken into account.

Place, publisher, year, edition, pages
BioMed Central, 2015
Keywords
Social inequality; Overweight; Obesity; Perception of overweight; Childhood; Adolescence
National Category
Clinical Medicine
Identifiers
urn:nbn:se:liu:diva-120339 (URN)10.1186/s12889-015-1985-x (DOI)000357559600001 ()26156095 (PubMedID)
Note

Funding Agencies|Erik Johan Ljungberg Educational Fund; County Council of Ostergotland; Medical Research Council of Southeast Sweden [FORSS-233111]

Available from: 2015-07-31 Created: 2015-07-31 Last updated: 2017-12-04
Abelius, M. S., Janefjord, C., Ernerudh, J., Berg, G., Matthiesen, L., Duchén, K., . . . Jenmalm, M. (2015). The Placental Immune Milieu is Characterized by a Th2- and Anti-Inflammatory Transcription Profile, Regardless of Maternal Allergy, and Associates with Neonatal Immunity. American Journal of Reproductive Immunology, 73(5), 445-459
Open this publication in new window or tab >>The Placental Immune Milieu is Characterized by a Th2- and Anti-Inflammatory Transcription Profile, Regardless of Maternal Allergy, and Associates with Neonatal Immunity
Show others...
2015 (English)In: American Journal of Reproductive Immunology, ISSN 1046-7408, E-ISSN 1600-0897, Vol. 73, no 5, p. 445-459Article in journal (Refereed) Published
Abstract [en]

PROBLEM: How maternal allergy affects the systemic and local immunological environment during pregnancy and the immune development of the offspring is unclear.

METHOD OF STUDY: Expression of 40 genes was quantified by PCR arrays in placenta, peripheral blood mononuclear cells (PBMC), and cord blood mononuclear cells (CBMC) from 7 allergic and 12 non-allergic women and their offspring.

RESULTS: Placental gene expression was dominated by a Th2-/anti-inflammatory profile, irrespectively of maternal allergy, as compared to gene expression in PBMC. p35 expression in placenta correlated with fetal Tbx21 (ρ = -0.88, P < 0.001) and IL-5 expression in PBMC with fetal galectin1 (ρ = 0.91, P < 0.001). Increased expression of Th2-associated CCL22 in CBMC preceded allergy development.

CONCLUSIONS: Gene expression locally and systemically during pregnancy was partly associated with the offspring's gene expression, possibly indicating that the immunological milieu is important for fetal immune development. Maternal allergy was not associated with an enhanced Th2 immunity in placenta or PBMC, while a marked prenatal Th2 skewing, shown as increased CCL22 mRNA expression, might contribute to postnatal allergy development.

Place, publisher, year, edition, pages
Wiley-Blackwell, 2015
National Category
Clinical Medicine Cell and Molecular Biology Immunology in the medical area
Identifiers
urn:nbn:se:liu:diva-114069 (URN)10.1111/aji.12350 (DOI)000352810200007 ()25491384 (PubMedID)
Available from: 2015-02-06 Created: 2015-02-06 Last updated: 2018-01-11
Abelius, M. S., Janefjord, C., Ernerudh, J., Berg, G., Matthiesen, L., Duchén, K., . . . Jenmalm, M. (2014). Gene expression in placenta, peripheral and cord blood mononuclear cells from allergic and non-allergic women.
Open this publication in new window or tab >>Gene expression in placenta, peripheral and cord blood mononuclear cells from allergic and non-allergic women
Show others...
2014 (English)Manuscript (preprint) (Other academic)
Abstract [en]

Background: The influence of maternal allergy on the development of immune responses and allergy in the offspring is not understood.

Objective: To investigate (i) if maternal allergy influences the gene expression locally in placenta, systemically in peripheral blood mononuclear cells (PBMC) and fetally in cord blood mononuclear cells (CBMC), (ii) if the gene expression in the placenta and PBMC influences the gene expression in CBMC and (iii) how the gene expression at birth relates to allergy development during  childhood.

Methods: A real-time PCR array was used to quantify forty immune regulatory genes in placenta, PBMC (gestational week 39) and in CBMC from 7 allergic and 12 non-allergic women and their offspring. Furthermore, quantitative real-time PCR was used to measure mRNA expression of Tbx21, GATA-3, Foxp3, RORC and CCL22 in CBMC, selected based on present PCR array results and previous protein findings in cord blood, in 13 children who developed and 11 children who did not develop allergy during childhood.

Results: The gene expression profile in the placenta revealed a T-helper (Th) 2-/anti-inflammatory environment as compared with gene expression systemically, in PBMC. Maternal allergy was associated with increased expression of p35 in PBMC and CBMC and p40 in placenta. Placental p35 expression correlated with fetal Tbx21 expression (Rho=-0.88, p<0.001) and maternal IL-5 expression in PBMC with fetal Galectin-1 (Rho=0.91, p<0.001) expression. Allergy development in the children was preceded by high mRNA expression of the Th2-associated chemokine CCL22 at birth.

Conclusion and clinical relevance: Gene expression locally and systemically during pregnancy influenced the offspring’s gene expression at birth, indicating an interplay between maternal and fetal immunity. Children developing allergy during childhood had an increased expression of the Th2-associated chemokine CCL22 at birth, indicating a Th2 skewing before disease onset. Maternal allergy was not associated with a Th2-dominance in placenta, PBMC or CBMC.

National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-106219 (URN)
Available from: 2014-04-29 Created: 2014-04-29 Last updated: 2015-03-25Bibliographically approved
Sonnenschein-van der Voort, A. . M., Arends, L. R., de Jongste, J. C., Annesi-Maesano, I., Arshad, S. H., Barros, H., . . . Duijts, L. (2014). Preterm birth, infant weight gain, and childhood asthma risk: A meta-analysis of 147,000 European children. Journal of Allergy and Clinical Immunology, 133(5), 1317-1329
Open this publication in new window or tab >>Preterm birth, infant weight gain, and childhood asthma risk: A meta-analysis of 147,000 European children
Show others...
2014 (English)In: Journal of Allergy and Clinical Immunology, ISSN 0091-6749, E-ISSN 1097-6825, Vol. 133, no 5, p. 1317-1329Article in journal (Refereed) Published
Abstract [en]

Background: Preterm birth, low birth weight, and infant catch-up growth seem associated with an increased risk of respiratory diseases in later life, but individual studies showed conflicting results. Objectives: We performed an individual participant data meta-analysis for 147,252 children of 31 birth cohort studies to determine the associations of birth and infant growth characteristics with the risks of preschool wheezing (1-4 years) and school-age asthma (5-10 years). Methods: First, we performed an adjusted 1-stage random-effect meta-analysis to assess the combined associations of gestational age, birth weight, and infant weight gain with childhood asthma. Second, we performed an adjusted 2-stage random-effect meta-analysis to assess the associations of preterm birth (gestational age less than 37 weeks) and low birth weight (less than 2500 g) with childhood asthma outcomes. Results: Younger gestational age at birth and higher infant weight gain were independently associated with higher risks of preschool wheezing and school-age asthma (P less than. 05). The inverse associations of birth weight with childhood asthma were explained by gestational age at birth. Compared with term-born children with normal infant weight gain, we observed the highest risks of school-age asthma in children born preterm with high infant weight gain (odds ratio [OR], 4.47; 95% CI, 2.58-7.76). Preterm birth was positively associated with an increased risk of preschool wheezing (pooled odds ratio [pOR], 1.34; 95% CI, 1.25-1.43) and school-age asthma (pOR, 1.40; 95% CI, 1.18-1.67) independent of birth weight. Weaker effect estimates were observed for the associations of low birth weight adjusted for gestational age at birth with preschool wheezing (pOR, 1.10; 95% CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 95% CI, 1.01-1.27). Conclusion: Younger gestational age at birth and higher infant weight gain were associated with childhood asthma outcomes. The associations of lower birth weight with childhood asthma were largely explained by gestational age at birth.

Place, publisher, year, edition, pages
Elsevier, 2014
Keywords
Gestational age; low birth weight; infant growth; wheezing; asthma; children; cohort studies; epidemiology
National Category
Clinical Medicine
Identifiers
urn:nbn:se:liu:diva-107117 (URN)10.1016/j.jaci.2013.12.1082 (DOI)000335450700012 ()
Available from: 2014-06-05 Created: 2014-06-05 Last updated: 2017-12-05
Warstedt, K. & Duchén, K. (2013). Increased linoleic acid/alpha-linolenic acid ratio in Swedish cord blood samples collected between 1985 and 2005. European Journal of Nutrition, 52(2), 659-665
Open this publication in new window or tab >>Increased linoleic acid/alpha-linolenic acid ratio in Swedish cord blood samples collected between 1985 and 2005
2013 (English)In: European Journal of Nutrition, ISSN 1436-6207, E-ISSN 1436-6215, Vol. 52, no 2, p. 659-665Article in journal (Refereed) Published
Abstract [en]

Cord serum (CS) phospholipid fatty acid composition is associated with maternal diet during foetal life, and maternal intake of linoleic acid (LA, C18:2 omega-6) and alpha-linolenic acid (LNA, C18:3 omega-3) has been shown to influence the LA and LNA levels in CS. A possible connection between the increased incidence of atopic diseases and increased intake of LA and decreased intake of LNA in the Western world has been proposed. less thanbrgreater than less thanbrgreater thanThe aim of this study was to explore phospholipid fatty acid proportions and total IgE levels in CS from Swedish children, collected from 1985 to 2005, a period with increasing frequency of allergic diseases in Sweden, and reveal possible changes over time. less thanbrgreater than less thanbrgreater thanPhospholipid fatty acids and total IgE antibodies were analysed with gas chromatography and UniCAP(A (R)) technology, respectively, in 300 CS samples. less thanbrgreater than less thanbrgreater thanThe proportions of LA and LNA decreased significantly from 1985 to 2005 (p andlt; 0.001 for both). However, the LA/LNA ratio did increase (p andlt; 0.001), revealing a relatively larger decrease in LNA than in LA. No correlations were found between omega-6 and omega-3 fatty acids and total IgE antibodies in CS from newborn children. less thanbrgreater than less thanbrgreater thanThe LA/LNA ratio increased (p andlt; 0.001) in cord serum samples collected between 1985 and 2005, and no correlations between fatty acids and total IgE were found.

Place, publisher, year, edition, pages
Springer Verlag (Germany), 2013
Keywords
Cord blood, Fatty acids, Immunoglobulin E
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-90066 (URN)10.1007/s00394-012-0369-6 (DOI)000314970600023 ()
Note

Funding Agencies|Swedish Nutrition Foundation (SNF)||

Available from: 2013-03-21 Created: 2013-03-19 Last updated: 2017-12-06
Jenmalm, M. & Duchén, K. (2013). Timing of allergy-preventive and immunomodulatory dietary interventions: are prenatal, perinatal or postnatal strategies optimal?. Clinical and Experimental Allergy, 43(3), 273-278
Open this publication in new window or tab >>Timing of allergy-preventive and immunomodulatory dietary interventions: are prenatal, perinatal or postnatal strategies optimal?
2013 (English)In: Clinical and Experimental Allergy, ISSN 0954-7894, E-ISSN 1365-2222, Vol. 43, no 3, p. 273-278Article, review/survey (Refereed) Published
Abstract [en]

The increasing allergy prevalence in affluent countries may be caused by reduced microbial stimulation and a decreased dietary ω-3/ω-6 long-chain polyunsaturated fatty acid (LCPUFA) ratio, resulting in an abnormal postnatal immune maturation. The timing of allergy-preventive probiotic and ω-3 LCPUFA interventions is critical, as early-life events occurring during critical windows of immune vulnerability can have long-term impact on immune development. The maternal dietary and microbial environment during pregnancy may programme the immune development of the child. Prenatal environmental exposures may alter gene expression via epigenetic mechanisms, aiming to induce physiological adaptations to the anticipated postnatal environment, but potentially also increasing disease susceptibility in the offspring if exposures are mismatched. Although the importance of fetal programming mostly has been studied in cardiovascular and metabolic disease, this hypothesis is also very attractive in the context of environmentally influenced immune-mediated diseases. This review focuses on how prenatal, perinatal or postnatal ω-3 LCPUFA interventions regulate childhood immune and allergy development, and if synergistic effects may be obtained by simultaneous probiotic supplementation. We propose that combined pre- and postnatal preventive measures may be most efficacious. Increasing knowledge on the immunomodulatory effects of prenatal, perinatal and postnatal interventions will help to direct future strategies to combat the allergy epidemic.

Place, publisher, year, edition, pages
Blackwell Publishing, 2013
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-90064 (URN)10.1111/cea.12003 (DOI)000315099000004 ()23414535 (PubMedID)
Note

Funding Agencies|Swedish Research Council||Ekhaga Foundation||Research Council for the South-East Sweden||Swedish Asthma and Allergy Association||Olle Engkvist Foundation||Vardal Foundation - for Health Care Sciences and Allergy Research||

Available from: 2013-03-21 Created: 2013-03-19 Last updated: 2017-12-06
Furuhjelm, C., Warstedt, K., Fagerås Böttcher, M., Fälth-Magnusson, K., Larsson, J., Fredriksson, M. & Duchén, K. (2011). Allergic disease in infants up to 2 yr of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation inpregnancy and lactation. Pediatric Allergy and Immunology, 22(5), 505-514
Open this publication in new window or tab >>Allergic disease in infants up to 2 yr of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation inpregnancy and lactation
Show others...
2011 (English)In: Pediatric Allergy and Immunology, ISSN 0905-6157, E-ISSN 1399-3038, Vol. 22, no 5, p. 505-514Article in journal (Refereed) Published
Abstract [en]

We have previously reported a protective effect of maternal omega-3 long-chain polyunsaturated fatty acids (x-3 LCPUFA) supplementation in pregnancy and lactation on IgE-associated eczema and food allergy in the infant during the first year of life. Here we investigate whether the effects of the LCPUFA supplementation on IgE-associated diseases last up to 2 yr of age and assess the relationship between plasma proportions of x-3 PUFAs and the frequency and severity of infant allergic disease. 145 pregnant women, at risk of having an allergic infant, were randomized to daily supplementation with 1.6 g eicosapentaenoic acid (EPA) and 1.1 g docosahexaenoic acid (DHA) or placebo starting in the 25th gestational week and continuing through 3.5 months of breastfeeding. Clinical examinations, skin prick tests and analysis of maternal and infant plasma phospholipid fatty acids and infant specific IgE were performed. No difference in the prevalence of allergic symptoms was found between the intervention groups. Thecumulative incidence of IgE-associated disease was lower in the x-3-supplemented group (6/54, 13%) compared with the placebo group (19/62, 30%, p = 0.01). Higher maternal and infant proportions of DHA and EPA were associated with lower prevalence of IgE associated disease (p = 0.01–0.05) in a dose-dependent manner. Higher maternal and infant proportions of DHA and EPA were found if the infants presented none, when compared with multiple allergic symptoms, (p < 0.05) regardless of sensitization. In summary, the x-3 supplementation offered no obvious preventive effect on the prevalence of clinical symptoms of allergic disease, but the decrease in cumulative incidence of IgE-associated disease seen during the first year still remained until 2 yr of age. Furthermore, high proportions of DHA and EPA in maternal and infant plasma phospholipids were associated with less IgE-associated disease and a reduced severity of the allergic phenotype.

Place, publisher, year, edition, pages
John Wiley & Sons A/S, 2011
Keywords
allergy; eczema; fatty acids; pregnancy; lactation; dietary supplements; infant
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-61945 (URN)10.1111/j.1399-3038.2010.01096.x (DOI)000292931300009 ()
Note
Original Publication: Catrin Furuhjelm, Kristina Warstedt, Malin Fagerås Böttcher, Karin Fälth-Magnusson, Johanna Larsson, Mats Fredriksson and Karel Duchén, Allergic disease in infants up to 2 yr of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation inpregnancy and lactation, 2011, Pediatric Allergy and Immunology, (22), 5, 505-514. http://dx.doi.org/10.1111/j.1399-3038.2010.01096.x Copyright: John Wiley and Sons http://www.wiley.com/ Available from: 2010-11-18 Created: 2010-11-18 Last updated: 2017-12-12
Furuhjelm, C., Jenmalm, M. C., Fälth-Magnusson, K. & Duchén, K. (2011). Th1 and Th2 chemokines, vaccine induced 1 immunity and allergic disease in infants  after maternal ω-3 fatty acid supplementation during pregnancy and lactation. Pediatric Research, 69(3), 259-264
Open this publication in new window or tab >>Th1 and Th2 chemokines, vaccine induced 1 immunity and allergic disease in infants  after maternal ω-3 fatty acid supplementation during pregnancy and lactation
2011 (English)In: Pediatric Research, ISSN 0031-3998, E-ISSN 1530-0447, Vol. 69, no 3, p. 259-264Article in journal (Refereed) Published
Abstract [en]

We investigated whether the previously reported preventive effect of maternal ω-3 fatty acid supplementation on IgE-associated allergic disease in infancy may be mediated by facilitating a balanced circulating Th2/Th1 chemokine profile in the infant. Vaccine-induced immune responses at 2 y of age were also evaluated. Pregnant women, at risk of having an allergic infant, were randomized to daily supplementation with 1.6 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid or placebo from the 25th gestational week through 3.5 mo of breastfeeding. Infant plasma was analyzed for chemokines (cord blood, 3, 12, 24 mo) and anti-tetanus and anti-diphtheria IgG (24 mo). High Th2-associated CC-chemokine ligand 17 (CCL17) levels were associated with infant allergic disease (p < 0.05). In infants without, but not with, maternal history of allergy, the ω-3 supplementation was related to lower CCL17/CXC-chemokine ligand 11 (CXCL11) (Th2/Th1) ratios (p < 0.05). Furthermore, in nonallergic, but not in allergic infants, ω-3 supplementation was linked with higher Th1-associated CXCL11 levels (p < 0.05), as well as increased IgG titers to diphtheria (p = 0.01) and tetanus (p = 0.05) toxins. Thus, the prospect of balancing the infant immune system toward a less Th2-dominated response, by maternal ω-3 fatty acid supplementation, seems to be influenced by allergic status.

Place, publisher, year, edition, pages
Nature Publishing Group, 2011
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-61946 (URN)10.1203/PDR.0b013e3182072229 (DOI)000287621700014 ()21099447 (PubMedID)
Available from: 2010-11-18 Created: 2010-11-18 Last updated: 2017-12-12Bibliographically approved
Gustafsson, P., Birberg Thornberg, U., Duchén, K., Landgren, M., Malmberg, K., Pelling, H., . . . Karlsson, T. (2010). EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD. Acta Paediatrica, 99(10), 1540-1549
Open this publication in new window or tab >>EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD
Show others...
2010 (English)In: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 99, no 10, p. 1540-1549Article in journal (Refereed) Published
Abstract [en]

Aim: Measure efficacy of eicosapentaenoic acid (EPA) in children with attention deficit hyperactivity disorder (ADHD). Methods: Randomized controlled trial (RCT) of 0.5 g EPA or placebo (15 weeks) in 92 children (7-12 years) with ADHD. Efficacy measure was Conners Parent/Teacher Rating Scales (CPRS/CTRS). Fatty acids were analysed in serum phospholipids and red blood cell membranes (RBC) at baseline and endpoint with gas chromatography. Results: EPA improved CTRS inattention/cognitive subscale (p = 0.04), but not Conners total score. In oppositional children (n = 48), CTRS total score improved andgt;= 25% in 48% of the children receiving EPA vs. 9% for placebo [effect size (ES) 0.63, p = 0.01]. In less hyperactive/impulsive children (n = 44), andgt;= 25% improvement was seen in 36% vs. 18% (ES 0.41, n.s.), and with both these types of symptoms 8/13 with EPA vs. 1/9 for placebo improved andgt;= 25% (p = 0.03). Children responding to treatment had lower EPA concentrations (p = 0.02), higher AA/EPA (p = 0.005) and higher AA/DHA ratios (p = 0.03) in serum at baseline. Similarly, AA/EPA (p = 0.01), AA/DHA (p = 0.038) and total omega-6/omega-3 ratios (p = 0.028) were higher in RBC, probably because of higher AA (p = 0.011). Conclusion: Two ADHD subgroups (oppositional and less hyperactive/impulsive children) improved after 15-week EPA treatment. Increasing EPA and decreasing omega-6 fatty acid concentrations in phospholipids were related to clinical improvement.

Place, publisher, year, edition, pages
Blackwell Publishing Ltd, 2010
Keywords
ADHD, Arachidonic acid, DHA, EPA, LCPUFA, RBC, serum phospholipids
National Category
Social Sciences
Identifiers
urn:nbn:se:liu:diva-59732 (URN)10.1111/j.1651-2227.2010.01871.x (DOI)000281556700025 ()
Available from: 2010-09-24 Created: 2010-09-24 Last updated: 2017-12-12Bibliographically approved
Furuhjelm, C., Warstedt, K., Larsson, J., Fredriksson, M., Böttcher, M., Fälth-Magnusson, K. & Duchén, K. (2009). Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy. Acta Paediatrica, 98(9), 1461-1467
Open this publication in new window or tab >>Fish oil supplementation in pregnancy and lactation may decrease the risk of infant allergy
Show others...
2009 (English)In: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 98, no 9, p. 1461-1467Article in journal (Refereed) Published
Abstract [en]

Maternal intake of omega-3 (-3) polyunsaturated fatty acids (PUFAs) during pregnancy has decreased, possibly contributing to a current increased risk of childhood allergy. Aim: To describe the effects of maternal -3 long-chain PUFA supplementation during pregnancy and lactation on the incidence of allergic disease in infancy. Methods: One hundred and forty-five pregnant women, affected by allergy themselves or having a husband or previous child with allergies, were included in a randomized placebo-controlled trial. Daily maternal supplementation with either 1.6 g eicosapentaenoic acid and 1.1 g docosahexaenoic acid or placebo was given from the 25(th) gestational week to average 3-4 months of breastfeeding. Skin prick tests, detection of circulating specific immunoglobulin E (IgE) antibodies and clinical examinations of the infants were performed. Results: The period prevalence of food allergy was lower in the -3 group (1/52, 2%) compared to the placebo group (10/65, 15%, p andlt; 0.05) as well as the incidence of IgE-associated eczema (-3 group: 4/52, 8%; placebo group: 15/63, 24%, p andlt; 0.05). Conclusion: Maternal -3 fatty acid supplementation may decrease the risk of food allergy and IgE-associated eczema during the first year of life in infants with a family history of allergic disease.

Keywords
Allergy, Eczema, Lactation, Polyunsaturated fatty acids, Pregnancy
National Category
Medical and Health Sciences
Identifiers
urn:nbn:se:liu:diva-19806 (URN)10.1111/j.1651-2227.2009.01355.x (DOI)
Available from: 2009-08-11 Created: 2009-08-10 Last updated: 2017-12-13
Organisations

Search in DiVA

Show all publications